person

Torgeir W.

Country
Norway
Department
Clinic of Cardiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Cardiovascular Disease Management

Clinical investigation of chronic heart conditions with a focus on improving outcomes for patients affected by Heart Failure, Atrial Fibrillation, Coronary Artery Disease, and stress‑induced cardiomyopathy.

  • Heart Failure management strategies
  • Atrial Fibrillation in advanced kidney disease
  • Coronary Artery Disease multi‑vessel interventions
  • Takotsubo Syndrome therapeutic approaches

Integrates guideline‑based care with innovative treatment pathways.

Cardio‑Oncology

Addresses cardiovascular complications arising from cancer therapies, aiming to mitigate cardiotoxic effects and support patients undergoing oncologic treatment.

  • Cardio‑Oncology risk assessment
  • Cancer‑related Cardiotoxicity monitoring
  • Cardiac dysfunction prevention in chemotherapy recipients
  • Anticoagulation in malignancy‑associated thrombosis

Promotes collaborative care models between cardiology and oncology units.

Metabolic and Endocrine Interactions

Investigates the impact of metabolic disorders on cardiac health, targeting therapeutic optimization for patients with diabetes, obesity, and hypertension.

  • Diabetes Mellitus cardiovascular risk reduction
  • Obesity management in heart disease
  • Hypertension control strategies
  • Metabolic Syndrome influence on cardiac outcomes

Emphasizes personalized medicine based on metabolic profiling.

Vascular Therapeutics

Explores antithrombotic and antiplatelet regimens to improve vascular outcomes post‑surgery and in acute coronary settings.

  • Antiplatelet Therapy after coronary artery bypass grafting
  • Anticoagulation in atrial fibrillation with renal impairment
  • Peripheral Vascular Disease interventions
  • Thromboembolic Prevention in high‑risk cohorts

Aligns with contemporary guidelines for vascular risk management.

Emerging Cardiovascular Innovations

Focuses on cutting‑edge therapeutic modalities, including gene‑based treatments, advanced device therapies, and novel pharmacologic agents.

  • Novel Cardiovascular Agents evaluation
  • Gene Therapy applications in cardiomyopathy
  • Device‑Based Interventions for arrhythmia control
  • Regenerative Medicine approaches for myocardial repair

Supports translational research bridging bench discoveries to clinical practice.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.